<DOC>
	<DOC>NCT02087189</DOC>
	<brief_summary>This clinical investigation is designed to confirm the safety and efficacy of the TD01 ICD lead.</brief_summary>
	<brief_title>TD01 Master Study (Safety and Efficacy Study)</brief_title>
	<detailed_description />
	<criteria>Meet standard indication for ICD/CRTD therapy First ICD/CRTD implantation or upgrade from pacemaker Duly signed informed consent form Willing to participate for the whole study duration Patient accepts Home Monitoring concept and is able to activate and use the CardioMessenger Patient has a legal capacity and ability to consent Meet a standard contraindication for an ICD/CRTD therapy Age &lt; 18 years Pregnant or breastfeeding Cardiac surgery planned within the next six months Enrollment in another cardiac clinical investigation with active treatment arm Mechanical tricuspid valve prosthesis or severe tricuspid valve disease Known dexamethasone acetate intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>ICD, CRT-D, lead</keyword>
</DOC>